{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T21:37:58Z","timestamp":1758231478701,"version":"3.44.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,27]],"date-time":"2025-07-27T00:00:00Z","timestamp":1753574400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["New Microbes and New Infections"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.nmni.2025.101617","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T16:22:06Z","timestamp":1753806126000},"page":"101617","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Can hair concentrations of artemether-lumefantrine be used as a tool to retrospectively determine drug exposure during malaria treatment?"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2691-8130","authenticated-orcid":false,"given":"Jenny L.","family":"Schnyder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marloes","family":"Vos-van der Meer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinier M.","family":"van Hest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron","family":"Mathot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Schlagenhauf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna K.","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin P.","family":"Grobusch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2023","series-title":"WHO guidelines for malaria, 14 March 2023","key":"10.1016\/j.nmni.2025.101617_bib1"},{"issue":"1","key":"10.1016\/j.nmni.2025.101617_bib2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40794-025-00256-1","article-title":"Malaria recrudescence after artemether-lumefantrine treatment in travellers\u2013 a hospital-based observational study and literature review","volume":"11","author":"Schnyder","year":"2025","journal-title":"Trop Dis Travel Med Vaccines"},{"issue":"1","key":"10.1016\/j.nmni.2025.101617_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12936-024-04858-6","article-title":"msp1, msp2, and glurp genotyping to differentiate Plasmodium falciparum recrudescence from reinfections during prevention of reestablishment phase, Sri Lanka, 2014-2019","volume":"23","author":"Gunasekera","year":"2024","journal-title":"Malar J"},{"issue":"2","key":"10.1016\/j.nmni.2025.101617_bib4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.4269\/ajtmh.2008.78.241","article-title":"Treatment of acute uncomplicated falciparum malaria with artemether-lumefantrine in non-immune populations: a safety, efficacy, and pharmacokinetic study","volume":"78","author":"Hatz","year":"2008","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.nmni.2025.101617_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2019.101505","article-title":"Imported malaria and artemisinin-based combination therapy failure in travellers returning to Belgium: a retrospective study","volume":"32","author":"Rovira-Vallbona","year":"2019","journal-title":"Trav Med Infect Dis"},{"issue":"4","key":"10.1016\/j.nmni.2025.101617_bib6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/0049475513499560","article-title":"Imported Plasmodium falciparum malaria in Istanbul, Turkey: risk factors for severe course and mortality","volume":"43","author":"Arslan","year":"2013","journal-title":"Trop Doct"},{"key":"10.1016\/j.nmni.2025.101617_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2023.102549","article-title":"Artemether-lumefantrine, mefloquine and atovaquone-proguanil in the treatment of uncomplicated Plasmodium falciparum malaria in travellers: a retrospective comparative study of efficacy and treatment failures","volume":"52","author":"Grebenyuk","year":"2023","journal-title":"Trav Med Infect Dis"},{"key":"10.1016\/j.nmni.2025.101617_bib8","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taad114","article-title":"Emergence of artemisinin-based combination treatment failure in patients returning from sub-Saharan Africa with P. falciparum malaria","author":"Grossman","year":"2023","journal-title":"J Trav Med"},{"key":"10.1016\/j.nmni.2025.101617_bib9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.tmaid.2018.02.003","article-title":"Retrospective observational study of the use of artemether-lumefantrine in the treatment of malaria in Japan","volume":"22","author":"Nakamura-Uchiyama","year":"2018","journal-title":"Trav Med Infect Dis"},{"issue":"2","key":"10.1016\/j.nmni.2025.101617_bib10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/cid\/ciw710","article-title":"High rate of treatment failures in nonimmune travelers treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria in Sweden: retrospective comparative analysis of effectiveness and case series","volume":"64","author":"Sond\u00e9n","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.nmni.2025.101617_bib11","doi-asserted-by":"crossref","first-page":"828","DOI":"10.4269\/ajtmh.18-0722","article-title":"Imported malaria at a referral hospital in Tokyo from 2005 to 2016: clinical experience and challenges in a non-endemic setting","volume":"100","author":"Takaya","year":"2019","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.nmni.2025.101617_bib12","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s12916-015-0456-7","article-title":"Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: a systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data","volume":"13","year":"2015","journal-title":"BMC Med"},{"key":"10.1016\/j.nmni.2025.101617_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-020-03520-1","article-title":"Asymptomatic recrudescence after artemether\u2013lumefantrine treatment for uncomplicated falciparum malaria: a systematic review and meta-analysis","volume":"19","author":"Mumtaz","year":"2020","journal-title":"Malar J"},{"year":"2025","series-title":"Malaria recrudescence after artemether\/lumefantrine treatment in travellers \u2013 a hospital-based observational study and literature review","author":"Schnyder","key":"10.1016\/j.nmni.2025.101617_bib14"},{"issue":"1","key":"10.1016\/j.nmni.2025.101617_bib15","article-title":"Strong relationship between oral dose and tenofovir hair levels in a randomized trial: hair as a potential adherence measure for pre-exposure prophylaxis (PrEP)","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.nmni.2025.101617_bib16","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00046-2019","article-title":"Association of anti-tuberculosis drug concentrations in hair and treatment outcomes in MDR-and XDR-TB","volume":"5","author":"Metcalfe","year":"2019","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.nmni.2025.101617_bib17","article-title":"Validated LC-MS\/MS panel for quantifying 11 drug-resistant TB medications in small hair samples","volume":"159","author":"Reckers","year":"2020","journal-title":"JoVE J"},{"key":"10.1016\/j.nmni.2025.101617_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2023.102590","article-title":"Hair concentrations of anti-malarials in returned travellers-the HAIR study: proof of principle analysis","volume":"54","author":"Steiner","year":"2023","journal-title":"Trav Med Infect Dis"},{"year":"2021","series-title":"Summary of product characteristic: Riamet 20 mg\/120 mg tablets","key":"10.1016\/j.nmni.2025.101617_bib19"},{"issue":"1\u20133","key":"10.1016\/j.nmni.2025.101617_bib20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0379-0738(96)02048-8","article-title":"Effect of pigmentation on the drug deposition in hair of grey-haired subjects","volume":"84","author":"Rothe","year":"1997","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.nmni.2025.101617_bib21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s004140050056","article-title":"Influence of the cosmetic treatment of hair on drug testing","volume":"110","author":"Jurado","year":"1997","journal-title":"Int J Leg Med"},{"issue":"1\u20133","key":"10.1016\/j.nmni.2025.101617_bib22","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.forsciint.2011.10.024","article-title":"Society of Hair Testing guidelines for drug testing in hair","volume":"218","author":"Cooper","year":"2012","journal-title":"Forensic Sci Int"},{"year":"2019","series-title":"Bioanalytical method validation M10","key":"10.1016\/j.nmni.2025.101617_bib23"},{"year":"2022","series-title":"Strategy to respond to antimalarial drug resistance in Africa","key":"10.1016\/j.nmni.2025.101617_bib24"},{"issue":"6","key":"10.1016\/j.nmni.2025.101617_bib25","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1742-1241.2001.tb11062.x","article-title":"Hair as a biological specimen for therapeutic drug monitoring","volume":"55","author":"Beumer","year":"2001","journal-title":"Int J Clin Pract"}],"container-title":["New Microbes and New Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2052297525000563?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2052297525000563?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T12:08:44Z","timestamp":1758197324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2052297525000563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":25,"alternative-id":["S2052297525000563"],"URL":"https:\/\/doi.org\/10.1016\/j.nmni.2025.101617","relation":{},"ISSN":["2052-2975"],"issn-type":[{"type":"print","value":"2052-2975"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can hair concentrations of artemether-lumefantrine be used as a tool to retrospectively determine drug exposure during malaria treatment?","name":"articletitle","label":"Article Title"},{"value":"New Microbes and New Infections","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmni.2025.101617","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101617"}}